Cycurion announces $6 million securities offering for growth and corporate purposes, involving shares and warrants to an institutional investor.
Quiver AI Summary
Cycurion, Inc., a company specializing in technology and staffing solutions for the public sector, announced a securities purchase agreement with an institutional investor for the sale of 1,657,460 shares of common stock and related warrants, generating approximately $6 million in gross proceeds at a price of $3.62 per share. The warrants will have an exercise price of $3.62 per share, becoming exercisable after shareholder approval, and will expire in five years. The net proceeds will be used for working capital and general corporate purposes. The closing of the offering is anticipated around December 5, 2025, pending customary closing conditions. A.G.P./Alliance Global Partners is acting as the sole placement agent. Cycurion aims to utilize this capital to further its growth strategy and enhance its position in AI-powered cybersecurity and government IT solutions.
Potential Positives
- Cycurion successfully raised approximately $6 million in gross proceeds through a securities purchase agreement, enhancing its financial position.
- The funds will support Cycurion's inorganic growth strategy and the continuation of execution on the company's backlog, potentially leading to increased revenue and market presence.
- The transaction involves warrants for additional shares, providing an opportunity for future capital raising and investment.
- The company's commitment to cybersecurity and AI solutions aligns with growing industry demands, positioning it favorably in the market.
Potential Negatives
- Entering into an agreement for a significant equity raise may signal to investors and the market that the company is in need of capital, raising concerns about its financial stability.
- The use of proceeds for working capital and general corporate purposes may indicate a lack of specific growth initiatives or projects, which could be seen as a lack of clear direction.
FAQ
What is the purpose of Cycurion's recent securities purchase agreement?
The agreement aims to raise approximately $6 million for working capital and general corporate purposes.
How many shares are involved in Cycurion's securities offering?
Cycurion's offering includes 1,657,460 shares of common stock and warrants for 3,314,920 additional shares.
When is the expected closing date for the securities offering?
The closing of the offering is expected to occur on or about December 5, 2025, subject to customary closing conditions.
Who is the placement agent for this offering?
A.G.P./Alliance Global Partners is acting as the sole placement agent for Cycurion's securities offering.
What are Cycurion's main business focuses?
Cycurion specializes in cybersecurity, program management, and business continuity using AI-powered solutions for its clients.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CYCU Revenue
$CYCU had revenues of $3.8M in Q3 2025. This is a decrease of -13.87% from the same period in the prior year.
You can track CYCU financials on Quiver Quantitative's CYCU stock page.
$CYCU Hedge Fund Activity
We have seen 10 institutional investors add shares of $CYCU stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANE STREET GROUP, LLC added 336,871 shares (+inf%) to their portfolio in Q3 2025, for an estimated $132,760
- VIRTU FINANCIAL LLC removed 158,620 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $55,390
- TWO SIGMA SECURITIES, LLC removed 87,447 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,536
- HRT FINANCIAL LP removed 59,312 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,711
- GOLDMAN SACHS GROUP INC added 33,729 shares (+inf%) to their portfolio in Q3 2025, for an estimated $13,292
- UBS GROUP AG removed 16,478 shares (-44.3%) from their portfolio in Q3 2025, for an estimated $6,493
- GEODE CAPITAL MANAGEMENT, LLC removed 14,238 shares (-60.9%) from their portfolio in Q3 2025, for an estimated $5,611
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MCLEAN, Va., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. ("Cycurion" or the "Company") (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 1,657,460 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 3,314,920 shares of common stock at an effective combined price of $3.62 per share and common warrant for aggregate gross proceeds of approximately $6 million, before deducting placement agent fees and other offering expenses. The warrants will have an exercise price of $3.62 per share, will be exercisable immediately following receipt of shareholder approval and will expire five years from the initial exercise date.
The closing of the offering is expected to occur on or about December 5, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering for working capital and general corporate purposes.
A.G.P./Alliance Global Partners is acting as the sole placement agent in connection with the offering.
Kevin Kelly, Chairman and Chief Executive Officer of Cycurion, commented:
“We’re thrilled to enter into this $6 million at-the-market placement with a single institutional investor. This capital accelerates our inorganic growth strategy, fuels continued execution on our backlog and strengthens our push to lead in AI-powered cybersecurity and mission-critical government IT solutions.”
The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) covering the resale of the shares of common stock and shares of common stock underlying common warrants sold in the offering.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. More info: www.cycurion.com
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company’s anticipated use of proceeds from the offering; the acceleration of the Company’s inorganic growth strategy; the continued execution on the Company’s backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
[email protected]
Cycurion Media Relations:
(888) 341-6680
[email protected]